Aveanna Healthcare Hldgs Q1 2024 Adj EPS $(0.03) Beats $(0.05) Estimate, Sales $490.653M Beat $483.976M Estimate
Aveanna Healthcare Hldgs Q1 2024 Adj EPS $(0.03) Beats $(0.05) Estimate, Sales $490.653M Beat $483.976M Estimate
Aveanna Healthcare Holdgs 2024年第一季度調整後每股收益美元（0.03）超過預期（0.05），銷售額4.90653億美元超過預期的4.83976億美元
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 40 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $490.653 million which beat the analyst consensus estimate of $483.976 million by 1.38 percent. This is a 5.20 percent increase over sales of $466.413 million the same period last year.
Aveanna Healthcare Holdgs（納斯達克股票代碼：AVAH）公佈的季度虧損爲每股0.03美元，比分析師普遍預期的0.05美元（0.05美元）高出40％。這比去年同期每股虧損0.05美元（0.05）增長了40％。該公司公佈的季度銷售額爲4.90653億美元，比分析師普遍預期的4.83976億美元高出1.38％。這比去年同期的4.66413億美元的銷售額增長了5.20％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。